Free Trial
→ Do this before December or regret it (From Porter & Company) (Ad)tc pixel
NASDAQ:INBS

Intelligent Bio Solutions Q1 2027 Earnings Date & Estimates

Intelligent Bio Solutions logo
$1.48 -0.03 (-1.99%)
Closing price 10/13/2026 03:59 PM Eastern
Extended Trading
$1.52 +0.04 (+2.77%)
As of 10/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intelligent Bio Solutions is estimated to report Q1 2027 earnings on Wednesday, November 11, 2026, before market opens. The conference call is scheduled for November 9, 2026 at 9:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q1 2027
Announcement Date
Time
Before Market Opens
Conference Call Date
Conference Call
9:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Intelligent Bio Solutions in Q1 2027

Intelligent Bio Solutions is expected to post earnings of -$1.31 per share on revenue of $1.40 million. In the same quarter a year earlier Intelligent Bio Solutions reported -$3.50 per share on revenue of $1.11 million. Intelligent Bio Solutions last reported on May 13, 2026, posting -$1.80 per share and missing the $1.40 consensus estimate. Intelligent Bio Solutions has beaten the consensus EPS estimate in 1 of its last 6 quarters.

Consensus Estimates

Consensus EPS
-$1.31
Expected Revenue
$1.40 million
Prior-Year EPS
-$3.50
Prior-Year Revenue
$1.11 million
Expected Revenue Growth
+25.9%

Recent Track Record

Last Reported
Q3 2026
Last Quarter EPS
-$1.80 (Missed by -$3.20)
Last Quarter Revenue
$1.06 million
EPS Beat Rate
1 of last 6 quarters

Prepare for the Q1 2027 Call

Intelligent Bio Solutions Q1 2027 Earnings FAQ

Intelligent Bio Solutions (NASDAQ:INBS) is estimated to report Q1 2027 earnings on Wednesday, November 11, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Intelligent Bio Solutions' Q1 2027 earnings conference call is scheduled for Monday, November 9, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Intelligent Bio Solutions to post earnings of -$1.31 per share for Q1 2027.

The consensus revenue estimate for Intelligent Bio Solutions is $1.40 million for Q1 2027.

Intelligent Bio Solutions Earnings Headlines

Intelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System Transcript
September 24, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4949623-intelligent-bio-solutions-inc-inbs-discusses-fda-510-k-submission-and-progress-of-intelligent
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
September 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/10/3359498/0/en/intelligent-bio-solutions-to-host-virtual-fireside-chat-on-september-24th-at-4-30-p-m-et.html
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.tc pixel
 |  Paradigm Press (Ad)
Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
September 9, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-09/69535587-intelligent-bio-solutions-inc-intelligent-bio-solutions-submits-fda-510-k-package-for-intelligent-fingerprinting-drug-screening-system-seeking-u-399.htm
Intelligent Bio Solutions Seeks FDA Clearance For Fingerprint-Based Drug Screening System
September 9, 2026  |  rttnews.comhttps://www.rttnews.com/3689626/intelligent-bio-solutions-seeks-fda-clearance-for-fingerprint-based-drug-screening-system.aspx
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
September 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/09/3358636/0/en/intelligent-bio-solutions-submits-fda-510-k-package-for-intelligent-fingerprinting-drug-screening-system-seeking-u-s-market-clearance.html
See More Intelligent Bio Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email.

About Intelligent Bio Solutions

Intelligent Bio Solutions (NASDAQ:INBS) is a life sciences company developing rapid, non-invasive drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a person’s fingerprint to identify the presence of commonly used drugs.

The system combines a disposable drug-screening cartridge with a portable reader and associated software. By using fingerprint sweat rather than blood or urine, the company aims to provide a convenient testing option for organizations such as employers, law-enforcement agencies, drug-treatment providers and other healthcare or public-sector users.

Intelligent Bio Solutions has roots in the development of diagnostic technologies and was formerly known as GBS Inc. The company markets its fingerprint-based screening products internationally, including in the United Kingdom and other markets, subject to applicable regulatory and commercial requirements. The company is led by Chief Executive Officer Harry Simeonidis.

View Intelligent Bio Solutions Profile
Earnings Tools